Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clonidine 40micrograms/5ml oral suspension
0407042F0AABABA
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 45micrograms/5ml oral liquid
0407042F0AAAEAE
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 5micrograms/5ml oral liquid
0407042F0AAAJAJ
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 6.25micrograms/5ml oral liquid
0407042F0AAAPAP
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 62.5micrograms/5ml oral suspension
0407042F0AAAXAX
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 750micrograms/5ml oral liquid
0407042F0AAAIAI
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 75micrograms/5ml oral liquid
0407042F0AAAHAH
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clonidine 90micrograms/5ml oral liquid
0407042F0AAASAS
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | No data available |
|
Clopidogrel 11mg oral powder sachets
0209000C0AAAFAF
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 3.5mg oral powder sachets
0209000C0AAAPAP
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 4mg oral powder sachets
0209000C0AAAIAI
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 5mg oral powder sachets
0209000C0AAAMAM
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 6mg oral powder sachets
0209000C0AAANAN
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 6mg/ml oral suspension
0209000C0AAAQAQ
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 75mg oral powder sachets
0209000C0AAACAC
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopidogrel 7mg/ml oral suspension
0209000C0AAARAR
|
Clopidogrel | Clopidogrel | Cardiovascular System | No data available |
|
Clopixol Acuphase 100mg/2ml solution for injection ampoules
040201010BBABAB
|
Clopixol Acuphase | Zuclopenthixol acetate | Central Nervous System | No data available |
|
Closteril 100 modified-release tablets
1001010C0CGAAAF
|
Closteril | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Clostet vacc inj 0.5ml pre-filled syringes
1404000R0BFAAAG
|
Clostet | Tetanus | Immunological Products and Vaccines | No data available |
|
Clotiapine 40mg tablets
0402010AHAAAAAA
|
Clotiapine | Clotiapine | Central Nervous System | No data available |
|
Clotrimazole 1% powder
1310020H0AAADAD
|
Clotrimazole (Topical) | Clotrimazole | Skin | No data available |
|
Clove oil 10% / Lidocaine 0.7% dental liquid sugar free
120304000AAALAL
|
Generic compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Clozapine 100mg/5ml oral liquid
0402010C0AAAFAF
|
Clozapine | Clozapine | Central Nervous System | No data available |
|
Clozapine 200mg orodispersible tablets sugar free
0402010C0AAALAL
|
Clozapine | Clozapine | Central Nervous System | No data available |
|
Clozapine 50mg orodispersible tablets sugar free
0402010C0AAAJAJ
|
Clozapine | Clozapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.